Societe De Therapeutique Marocaine operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Societe De Therapeutique Marocaine with three other
pharmaceutical manufacturers in Africa:
Glaxo Smithkline Consumer Nig PLC
sales of 14.38 billion Naira [US$47.18 million]
(529.79 million Moroccan Dirhams [US$54.34 million]
Societe Adwya SA
based in Tunisia
(84.65 million Dinar [US$34.68 million]
Societe De Therapeutique Marocaine reported sales of 1.33 billion Moroccan Dirhams (US$136.03 million)
December of 2016.
increase of 14.8%
versus 2015, when the company's sales were 1.16 billion Moroccan Dirhams.
Sales at Societe De Therapeutique Marocaine have increased during each of the previous five years
(and since 2011, sales have increased a total of 41%).